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Abstract
A typical use case of ontologies is the calculation of similarity scores between items that
are annotated with classes of the ontology. For example, in differential diagnostics and dis-
ease gene prioritization, the human phenotype ontology (HPO) is often used to compare a
query phenotype profile against gold-standard phenotype profiles of diseases or genes.
The latter have long been constructed as flat lists of ontology classes, which, as we show
in this work, can be improved by exploiting existing structure and information in annota-
tion datasets or full text disease descriptions. We derive a study-wise annotation model of
diseases and genes and show that this can improve the performance of semantic similarity
measures. Inferred weights of individual annotations are one reason for this improvement,
but more importantly using the study-wise structure further boosts the results of the algo-
rithms according to precision-recall analyses. We test the study-wise annotation model for
diseases annotated with classes from the HPO and for genes annotated with gene ontol-
ogy (GO) classes. We incorporate this annotation model into similarity algorithms and
show how this leads to improved performance. This work adds weight to the need for
enhancing simple list-based representations of disease or gene annotations. We show
how study-wise annotations can be automatically derived from full text summaries of dis-
ease descriptions and from the annotation data provided by the GO Consortium and how
semantic similarity measure can utilize this extended annotation model.
Database URL: https://phenomics.github.io/
Background
Ontologies have become a widely used tool to capture know-
ledge about objects in biology, genomics and medicine.
Besides enabling knowledge integration and retrieval, they
are also a widely used tool for similarity calculation between
items that have been described (annotated) with classes of an
ontology (1). Reliable ontology-based similarity measures are
important, as they form the basis of several applications for
differential diagnostics (2), disease gene finding (3), gene
function prediction (4) and many more. Ontology-based
similarity measures allow non-perfect matches between
ontology-classes to be quantified by incorporating the graph
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structure of the ontology. Often used similarity measures
include semantic similarity measures based on Resnik’s defin-
ition of shared information content [IC (5)], cosine similarity
measure and the Jaccard index (1).
In the fields of human genetics, genomics and precision
medicine, the Human Phenotype Ontology [HPO (6, 7)] is
often chosen to store the information about the clinical fea-
tures of patients in a computer-interpretable way. In most
applications of the HPO, a similarity measure is used to
compare a phenotype profile of a patient against a set of
diseases or genes, which itself are represented as a gold-
standard set of HPO classes (2, 3, 8). The result of this step
is a quantification of the similarity or overlap of the query
profile and the gold-standard profile. Similarly, a typical
application of the Gene Ontology [GO (9)] is the search
for similar proteins for a given query protein described as a
set of GO classes known to be associated with this protein.
A critical part of this process is the comparison of a query
set of ontology classes against a gold-standard set of ontology
classes associated with an item, such as a disease or a protein.
These gold-standard profiles are often represented as flat lists.
In human genetics, gold-standard profiles were con-
structed from human-written summary tables of clinical
features. For example, the clinical synopsis section of the
Online Mendelian Inheritance in Man database [OMIM
(10, 11)] database provides a tabular view of the clinical
features seen in patients with a particular disease.
Orphanet provides a similar list of clinical features for
each Orphanet disease entry but encodes these directly as
HPO classes (12, 13). Accordingly, the HPO project, until
now provides flat lists of HPO classes for each disease or
disease gene, which we call ‘merged’ annotation model.
However, full text disease descriptions often have an inher-
ent structure, which we aim to use in this work. In
OMIM’s full text description, each paragraph often repre-
sents a summary of a certain publication, study or disease
aspect. Similarly, GO-annotations often have references to
PubMed articles where a particular annotation has been
derived from.
The hypothesis of this work is that standard semantic
similarity measures can be improved by extending the stand-
ard ‘merged’ annotation model with additional information
(‘study-wise’ annotation model) that can be easily extracted
from the accompanying full text description in OMIM or the
meta-information available in the GO annotation data set.
Materials and methods
We first show how we construct a study-wise annotation
model for annotations with the HPO and GO. We introduce
semantic similarity measures that take into account weights
of individual phenotypes and the study-wise structure of the
annotation data. Finally, we present the data and approach
we chose for evaluating the hypotheses of this work.
Text mining of OMIM full text
We obtained one of the last freely downloadable versions
of omim.txt (last updated on 8 January 2016) and wrote
a parser that extracts the full text description for all
OMIM entries that the HPO project provides annotations
for (6916 in total). The full text description of OMIM
is structured according to multiple sections, such as
‘biochemical features’, ‘molecular genetics’ or ‘clinical
features’. We aimed to identify HPO classes associated
with patients who are diagnosed with OMIM entries. To
prevent false positive associations, we restrict our text min-
ing procedure to the sections ‘description’, ‘other features’,
‘biochemical features’, ‘diagnosis’, ‘clinical features’ and the
introductory section that usually has no header.
The text in the OMIM-sections is organized into mul-
tiple paragraphs—it is this paragraph structure that we
aim to investigate in this work. To give an example, the
OMIM entry for Alzheimer disease (OMIM: 104300) con-
tains the paragraph
Yan et al. (1996) reported that the . . .was particularly
increased in neurons close to deposits of amyloid beta
peptide and to neurofibrillary tangles.
This paragraph is later followed by the paragraph
Bergeron et al. (1987) found that . . . findings suggested
that cerebral amyloid angiopathy is an integral compo-
nent of AD.
The assumption is that each paragraph roughly corres-
ponds to one study. We thus split the text into separate
paragraphs and used the NCBO annotator (14) to identify
HPO classes in each paragraph. We then stored the found
matches together with the paragraph index, i.e. we gener-
ate a file that contains lines such as
104300 HP_0002185 NEUROFIBRILLARY TANGLES 23
104300 HP_0011970 CEREB. AMYLOID ANGIOPATHY 25
which means that NCBO annotator found the HPO class
for ‘Neurofibrillary tangles’ (HP_0002185) in the 23rd
paragraph of the OMIM entry with the ID 104300. The
next line lists the occurrences of ‘Cerebral amyloid
angiopathy’ (HP_0011970) in the 25th paragraph of the
same OMIM entry. We will infer from this data the study-
wise annotation model by assuming that each paragraph
represents one study.
GO annotations
We downloaded the GO obo-version from http://purl.oboli
brary.org/obo/go-basic.obo (date: 10 May 2017) and the
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GO annotation data from ftp://ftp.ncbi.nlm.nih.gov/gene/
DATA/gene2go.gz (date: 10 May 2017). Note that we only
considered GO classes from the biological process (BP) sub
ontology. We used all human gene to GO-BP class associ-
ations that have at least one PubMed reference, as we used
those for deriving the study-wise annotation sets for each gene.
Annotation models
In this work, we test four different annotation models that
can be generated from the annotation data described be-
fore. We introduce a merged (‘merged’), weighted [‘merged
(weighted)’], study-wise (‘study-wise’) and randomized
study-wise model [‘study-wise (shuffled)’]. An illustration
of these models is shown in Figure 1.
The merged annotation model (‘merged’) resembles
the model that is currently widely used, e.g. in the annota-
tion file provided by the HPO. Here, each ontology class
is listed once in a flat list with no additional structure.
The study-wise annotation model creates an annotation
list for each study. For the HPO, this corresponds to each
paragraph of the full text disease description from OMIM
that was considered in this work (i.e. we did not consider all
sections as described before). For GO, this corresponds to
each PubMed article referenced in the annotation data.
To investigate the influence of the actual annotations
per study and to exclude other factors introduced by the
studies (e.g. the number of studies per disease/gene), we
also use a randomized version of this annotation model
[called ‘study-wise (shuffled)’], where we kept the number
of studies and the number HPO/GO classes per study con-
stant, but randomly exchanged annotations between stud-
ies of each disease/gene. We perform this exchange
between two randomly chosen HPO/GO classes from two
randomly chosen studies 1000 times per disease/gene.
One of the obvious differences between the annotation
models ‘merged’ and ‘study-wise’ is the number of associ-
ated HPO/GO classes per study, because multiple occur-
rences of one ontology class per disease/gene are allowed
in the latter model (see Figure 1). To investigate the influ-
ence of this criterion, we also introduce the annotation
model ‘merged (weighted)’, where we use one flat list of
associated ontology classes, but each class is listed as often
as it occurs in different studies. Figure 1 illustrates the four
different annotation models using an artificial example dis-
ease and artificial HPO annotations.
Similarity measures
We chose to test three widely used semantic similarity
measures to quantify the overlap between a query Q and
an item I (an item is a disease or a gene in our case). Here,
each of these measures is capable of taking into account
the number of occurrences of a particular HPO/GO class
in Q and in I. This means, that measures are able to make
use of duplicated annotations in the model ‘merged
(weighted)’. We also introduce a method to apply the
measures to the study-wise annotation model.
Unweighted and weighted semantic similarity measures
We took a standard semantic similarity measure, which is
based on Resnik’s definition of IC. For each class c in the
ontology, the IC(c) is defined as the negative logarithm of
the frequency of annotations of items with the class (5),
i.e. IC(c)¼ log(pc), where pc is the observed frequency
of items annotated with class c among all annotated
items.
The similarity between two ontology classes (c1, c2) is
then calculated as the IC of their most informative common
Figure 1. Contrived symptom annotation set for one disease under the different annotation models tested in this study. In the ‘merged’ model every
symptom is listed exactly once and no further structure is given. In the ‘study-wise’ model, the symptoms associated with the disease are organized
by three studies that mention the symptoms. Note that each symptom may be mentioned in multiple studies. In the shuffled version of the ‘study-
wise’ model, each symptom from a study is randomly switched with a symptom from another study. Finally, the ‘merged (weighted)’ model removes
the structure defined by the studies but keeps the number of mentions for each symptom as derived from the ‘study-wise’ model.
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ancestor [MICA(c1, c2)], i.e. the common ancestor with the
highest IC (5). The set of common ancestors is the set of
ontology classes that subsume both c1 and c2. For this paper,
we define the semantic similarity between the annotated
ontology classes of a query (Q) and the annotated classes of
an item (I) as






ICðMICA c1; c2ð ÞÞ (1)
Note that jQj returns the number of ontology classes in
the set Q. For the unweighted version, each ontology class
in Q and I is uniquely present, for the weighted version,
the sets Q and I may contain duplicate entries. BMA stands
for best match average (1).
Other widely used similarity measures are the Cosine
similarity and the Jaccard index. To apply these, the query
Q is transferred to a vector representation q, where each
entry represents the number of occurrences of the corres-
ponding ontology class. For the unweighted version, each
of the entries is set to 1, if the corresponding ontology class
is present in the set and 0 otherwise. We do the same for
the item I, i.e. it is transferred to the vector i. Note that
during the transformation, all the ancestors of the classes
in Q and I are set to the corresponding count (or 1 in the
unweighted case).
The Cosine similarity measures the cosine of the angle be-
tween two non-zero vectors (here q and i) and is defined as







Finally, we tested the Jaccard index. The input is the
same as for the Cosine measures, i.e. the transformation of
Q and I into a vector representation q and i. The Jaccard
index is then computed as





Again, in the unweighted setting, each entry in the vec-
tors can be either 1 or 0, but in the weighted setting, the
entries represent the number of occurrences of the corres-
ponding ontology class in Q (or I).
Paragraph-wise similarity measures
In this work, we extend the flat list representation of gold
standard annotations (Q, I) by a study-wise model, such
that we replace the list of annotated HPO or GO classes
per disease or gene with multiple separate lists per disease
or gene (see Figure 1). The similarity in the study-wise an-
notation model is the defined as








where Qs and Is are defined as the set of studies Each study
sx represents a list of ontology classes that were identified
in the corresponding study. This simply means that for
each study in the query, we try to identify the most similar
study for the item. The final score is just the average of
similarities between the studies. The function Sim(pq, pd) is
a placeholder for one of the standard semantic similarity
measures described in the previous section, i.e. Resnik
BMA [equation (1)], Cosine [equation (2)] or Jaccard
[equation (3)]. Intuitively, this method takes each para-
graph from the query and tries to identify the best match-
ing paragraph in the item.
Evaluation using OMIM phenotypic series and
pathway membership
In order to test the different annotation models, we chose
to use pre-defined groupings of diseases and genes. The
goal is to re-identify group members given one member as
query using the similarity measures described earlier.
HPO-phenoseries test
For HPO, we used OMIM phenotypic series data, which is
a tabular representation for viewing at genetic heterogeneity
of similar phenotypes (10). One example of a phenotypic
series is ‘reticulate pigment disorders’, which has six mem-
bers. The idea is to use the HPO annotations of one member
of a phenotypic series as query (e.g. ‘Dowling-Degos disease
1’, OMIM: 179850) and rank all OMIM entries by seman-
tic similarity to that query. We record the rank of the other
members of the phenotypic series (e.g. ‘Dyschromatosis
symmetrica hereditaria’, OMIM: 127400). The goal is to
list all the other members on the first ranks, i.e. in front of
all non-members. The test only considered phenoseries
groups with at least two diseases after removing all diseases
that had <5 HPO annotations and <4 different studies.
This applied to 233 phenoseries.
Note that we did not aim to generate a more detailed
or deeper HPO annotation data set than the existing one
but rather want to show that for the one annotation set
derived from mining OMIM full text descriptions, meta
information on the annotations contains valuable infor-
mation. We thus did not compare the performance to
the existing gold-standard flat list: The aim was to show
that for this annotation set, a more sophisticated model
such as the ‘study-wise’-annotation model outperforms
a flat list (‘merged’) representation, which is currently
applied.
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GO-BP-pathway test
For GO, we obtained gene-to-pathway associations from
KEGG (15) by downloading the file http://rest.kegg.jp/
link/pathway/hsa (date: 19 September 2017). Similar to the
OMIM test, we took one gene from each pathway and
used its GO annotations to the ‘biological process’ sub
ontology (GO-BP) to calculate a similarity to all other
human genes. The test only considered pathways with at
least two genes but not >15 genes left, after removing all
genes that had <5 GO-BP annotations and <4 different
studies. This applied to 89 pathways.
Performance evaluation
As written before, we test the performance of the different
similarity measures and annotation models by trying to
identify all group members given one member as query.
We record the ranks of all other members; whereby low
ranks are better. We draw the rank distribution of the ob-
tained ranks and plot them as box and violin plots. A box
plot shows 50% of the data points surrounding the median
in the box and the position displays the skewness of the
data. The whiskers extend to the most extreme data point
that is no >1.5 times the length of the box away from the
box. Violin plots are similar, except that they also show
the probability density of the data at different values. We
use an overlay of a box and violin plots. To test for signifi-
cant improvements of the rank distributions, we use
Wilcoxon signed rank test with continuity correction, a
non-parametric test for two unrelated, not normally dis-
tributed samples [function wilcox.test(x, y, paired¼T, al-
ternative¼‘less’) in R].
We also use precision recall curves (PRC), which are
visual representations of the performance of a model in
terms of the precision and recall statistics. For different
thresholds, it plots the actual precision (y-axis) and recall
(x-axis) points and connects them by a line. An important
measure is the area under the precision recall curve (AU-
PRC), which is to be maximized.
Results
In this work, we tested four different annotation models,
in particular we investigate a model that incorporates the
information about the study or publication that a particu-
lar annotation has been based upon (see Materials and
methods). Figure 1 illustrates the different annotation
models tested in this work.
GO and HPO annotation data sets
In total, we annotated 6475 OMIM entries with at least
one HPO class from the HPO sub ontology ‘Phenotypic
abnormality’ (HP: 0000118) using the NCBO Annotator
(14). For these OMIM entries, we have identified 29 202
paragraphs/studies with at least one HPO class, i.e. on
average each disease has 4.5 paragraphs/studies in our
dataset. In the ‘merged’ annotation model, each disease has
on average 14.1 HPO annotations, whereas in the ‘study-
wise’ annotation model, each disease has 21.3 HPO anno-
tations. The reason for this discrepancy is the missing
uniqueness constraint. Each study/paragraph has a mean
number of 4.73 HPO annotations.
For the GO test, we used 10 608 genes that are anno-
tated with at least one GO class from GO-BP (biological
process). We have identified 30 104 PubMed-references
and on average each gene has 2.8 PubMed-references
(studies). Using the ‘merged’ annotation model each gene
has on average 4.5 GO-BP annotations. In the ‘study-wise’
annotation model, each disease has 5.1 GO-BP annota-
tions. Each study/PubMed-reference has a mean number of
1.8 GO-BP annotations.
The distribution of the annotation size (i.e. the distribu-
tion of the number of ontology classes associated with an
item or a study) is here analysed using quantiles (function
quantile in R). Here, we report the numbers for which five
5% and 95% of the data is smaller. For all tested annota-
tion models (GO-BP ‘merged’, GO-BP ‘study-wise’, HPO
‘merged’, HPO ‘study-wise’) the 5% quantile is 1.
However, the 95% quantile differs significantly between
the ‘merged’ and the ‘study-wise’ annotation data set, i.e.
15 vs. 4 for GO-BP and 43 vs. 14 for HPO. This shows
that the annotation size distribution for the ‘study-wise’
model is more homogeneous than the distribution for the
‘merged’ model.
Performance of study-wise similarity measures
We analysed if the annotation model currently in use can
be improved by employing a study-wise annotation model.
For the HPO, we derived the study-wise annotations by
analysis of OMIMs full text descriptions. For GO, we used
the PubMed identifiers often available for an association
between a gene and a GO class.
We tested four different annotation models and three
different similarity measures in two tests, the HPO-
phenoseries and the GO-BP-pathway test (see Materials
and methods). We found that the study-wise model outper-
forms almost all the other models in the tests according to
the modes of evaluation chosen.
Figure 2 plots the rank distributions of the sought items
in the HPO-phenoseries Test (2 A) and for the GO-BP-
pathway Test (2 B) using violin and box plot (see Materials
and methods). The ranks are obtained by sorting all dis-
eases or genes by semantic similarity and recording on
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which place (rank) the sought item was found, i.e. a lower
rank means better performance. The advantage of the
study-wise annotation model is especially apparent in the
HPO-phenoseries test.
Interestingly, the ‘merged (weighted)’ model already im-
proves the performance of the similarity measures, but the
study-wise model often outperforms the other models by a
large margin. This was confirmed by Wilcoxon signed
rank test (see Materials and methods), which resulted in
significant P-values for all measures in the HPO-
phenoseries test, when comparing ranks using the ‘study-
wise’ annotation model with all other annotation models
(P< 2.6*e161). For the GO-BP-pathway test, the results
are different. Here, only the Cosine and Jaccard results are
highly significant (P< 1.05*e128) when comparing the
merged and the study-wise annotation model. For Resnik
BMA only the comparison of the ranks obtained by study-
wise and the randomized study-wise model is significant
(P< 0.0002). For the cosine similarity measure, we also see
a significant difference between the study-wise and the
‘merged (weighted)’ model.
In Table 1, we list the improvements in terms of in-
crease in the AU-PRC. Figure 3 shows the precision recall
curves for the ‘merged’ and ‘study-wise’ annotation model
for all tested similarity measures. Except for one case, the
latter annotation model obviously improves the results of
the precision recall analysis. Only the GO-BP pathway test
for the Resnik methods show almost no change with only a
negligible increase in the AU-PRC of 0.007 (c.f. Table 1).
In Figure 4, we see the PRCs for the Jaccard similarity
measure, which again shows that the ‘merged (weighted)’
and ‘study-wise (shuffled)’ models show an improvement.
As seen before, the study-wise structure contains
valuable information, which leads to a further perform-
ance improvement.
Discussion
This work has investigated if using one simple flat list of
ontology classes for describing an item is an optimal anno-
tation model. Usually multiple studies are underlying such
an annotation set and we have thus inferred a study-wise
annotation model for disease being annotated with classes
of the HPO and for genes being annotated with classes of
the GO-BP. We tested different semantic similarity meas-
ures that are capable of using both annotation modes and
analysed their performance in recovering item-groupings
defined by biomedical knowledge, i.e. OMIM phenoseries
members using HPO and KEGG pathway members using
GO-BP. We find that the study-wise annotation model in
almost all tests significantly outperforms the merged anno-
tation model. The results show that the hypothesis of this
work is supported stronger when using HPO-phenoseries
test. The difference in performance advantage is probably
Figure 2. Box and violin plots (log-scaled) for the two tests performed in this project. (A) Shows the results for the HPO-phenoseries test and (B)
shows the same for GO-BP-pathway test. The plots show the distribution of the ranks of the sought members of the corresponding group (i.e.
Phenoseries members and KEGG pathway members). The lower a rank the better, because the sought disease/gene has been ranked before more
diseases/genes that were not considered to be sought. We tested three different ranking methods (Resnik BMA, Cosine and Jaccard) and four differ-
ent annotation models.
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due to the low number of annotation per study (1.8 vs.
4.7) in the GO-BP-pathway test. Also, we expect more het-
erogeneity in GO-BP annotations for genes in one pathway
compared to rather homogeneous HPO annotations for
members of a phenotypic series.
The HPO-phenoseries test investigated the ability of the
presented ideas to improve disease-clustering. However,
often patient phenotypes are compared against disease
entities and it will be interesting to see if the ideas pre-
sented here also improve the performance of similarity al-
gorithms in this setting (2), even if it is impossible to
generate study-wise annotations for a single patient.
The results obtained by the study-wise approach are not
only important for developers of ontology-based algorithms
for semantic similarity but also an important message for
database curators and developers. It is essential to keep the
provenance of annotations, i.e. why a particular association
between an item and an ontology class has been made.
Unfortunately, this has not been done for the ‘clinical synop-
sis’ in OMIM (at least not publicly available) and will
Figure 3. PRC for two annotation models (‘merged’ and ‘study-wise’) and for the three different ranking methods. (A) and (B) Show the results for the
HPO-phenoseries test and the GO-BP-pathway test, respectively. The differences in the area under PRC are listed in Table 1.
Figure 4. Precision recall plots for the Jaccard method and all four annotation models tested in this work. (A) and (B) Show the results for the HPO-
Phenoseries- and GO-BP-pathway test, respectively. One can see that the ‘merged (weighted)’ model already improves the performance, but that the
study-wise model outperforms all other models.
Table 1. Improvement using the ‘study-wise’ annotation
model in comparison to the ‘merged’ annotation model
measured by AU-PRC
Algorithm Increase in AU-PRC with ‘study-wise’
annotation model
HPO-Phenoseries test GO-BP-Pathway test
RESNIK BMA þ0.07 þ0.006
COSINE þ0.19 þ0.028
JACCARD þ0.20 þ0.027
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require a significant amount of work in the future to add
this information. However, it is relatively simple for data-
base curators to keep track of the provenance of associ-
ations in the future.
More research into the underlying mechanism of the
demonstrated improvements is needed. One explanation
might be the exclusion of false combinations of annota-
tions in the study-wise annotation model, which are other-
wise introduced by merging all annotated ontology classes
into one list. Another explanation might be that using
study-wise annotations sets, we derive a way more homo-
geneous distribution of annotation sizes (see Results) with
fewer entries having an extremely high number of annota-
tions. The effect of annotation size on the performance of
semantic similarity measures has been subject of research
in recent years (2, 16, 17).
Future work will include the implementation of the pre-
sented ideas into Bayesian algorithms (18). We think the
results of this work add weight to the need for improved
annotation data for items in parallel to continued research
into semantic similarity algorithms. This work is not only
relevant for HPO and GO-BP, but also, theoretically, for
all ontologies that are used to describe the properties and
characteristics of items.
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